Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias

Ivana Gojo*, Anchalee Jiemjit, Jane B. Trepel, Alex Sparreboom, William D. Figg, Sandra Rollins, Michael L. Tidwell, Jacqueline Greer, Joo Chung Eun, Min Jung Lee, Steven D. Gore, Edward A. Sausville, James Zwiebel, Judith E. Karp

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

262 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry